Elotuzumab, an MM drug that targets HLH-linked gene SLAMF7, has 5 PML cases reported in FAERS and for one case report the MM patient developed PML during treatment with lenalidomide and elotuzumab (93). The gene discussed is SLAMF7; the disease is Miyoshi myopathy.